Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) (Xolair)

This study has been completed.
Information provided by:
University of California, Davis Identifier:
First received: August 19, 2006
Last updated: May 25, 2011
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)